QHM-2025-7241 A87008.99C..01

The procurement process conducted by the NHS North East and North Cumbria Integrated Care Board involves the direct award of a contract for health services, covering activities such as PSA Monitoring, Diabetes Care Planning, and Shared Care Drug Monitoring, among others. Located in the UKC region, the awarding process follows the Health Care Services (Provider Selection Regime) regulations of 2023, exempt from the Procurement Regulations 2024. The process is at the award stage and the contract, valued nominally at £0.01 due to its activity-based nature, commenced on 1 April 2025 and will conclude on 31 March 2026.

The Marine Avenue Medical Centre was selected as the supplier using a limited procurement method justified by there being no realistic alternative provider, handled under the Direct Award Process A. This tender presents opportunities for large healthcare service providers who specialise in or can deliver integrated care services such as diabetes care and drug monitoring. Businesses located in or near the Sunderland area, particularly those with prior engagements in health services under complex regulatory frameworks, might find this an advantageous opportunity to demonstrate their capabilities.

With the healthcare sector experiencing dynamic changes, this offers potential growth in securing future contracts in the public healthcare domain. Although the current contract is awarded, companies with the requisite skills and capabilities should monitor similar opportunities that may arise within the integrated care system or related contracts under the Provider Selection Regime regulations.